SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-02-004008
Filing Date
2002-08-14
Accepted
2002-08-14 12:58:00
Documents
7
Period of Report
2002-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q j4192_10q.htm 10-Q 485608
3 EX-3.3 j4192_ex3d3.htm EX-3.3 36702
4 EX-3.6 j4192_ex3d6.htm EX-3.6 82489
5 EX-10.1 j4192_ex10d1.htm EX-10.1 49432
6 EX-10.2 j4192_ex10d2.htm EX-10.2 23063
7 EX-10.3 j4192_ex10d3.htm EX-10.3 49720
8 EX-10.4 j4192_ex10d4.htm EX-10.4 51083
  Complete submission text file 0001104659-02-004008.txt   780334
Mailing Address 236 WEST CUMMINGS PARK WOBURN MA 01801
Business Address 236 WEST CUMMINGS PARK WOBURN MA 01801 6179326616
ANIKA THERAPEUTICS INC (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14027 | Film No.: 02733540
SIC: 2836 Biological Products, (No Diagnostic Substances)